Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors
A novel series of homo- and heterodimeric ligands containing κ/μ agonist and μ agonist/antagonist pharmacophores joined by a 10-carbon ester linker chain were synthesized and evaluated for their in vitro binding affinity at κ, μ, and δ opioid receptors, and their functional activities were determine...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2011-05, Vol.19 (9), p.2808-2816 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A novel series of homo- and heterodimeric ligands containing κ/μ agonist and μ agonist/antagonist pharmacophores joined by a 10-carbon ester linker chain were synthesized and evaluated for their in vitro binding affinity at κ, μ, and δ opioid receptors, and their functional activities were determined at κ and μ receptors in [
35S]GTPγS functional assays. Most of these compounds had high binding affinity at μ and κ receptors (
K
i values less than 1
nM). Compound
15b, which contains butorphan (
1) at one end of linking chain and butorphanol (
5) at the other end, was the most potent ligand in this series with binding affinity
K
i values of 0.089
nM at the μ receptor and 0.073
nM at the κ receptor. All of the morphinan-derived ligands were found to be partial κ and μ agonists; ATPM-derived ligands
12 and
11 were found to be full κ agonists and partial μ agonists. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2011.03.052 |